How Medical Device Manufacturing is Transforming U.S. Healthcare Innovation

An aging U.S. population and increasing chronic illnesses like diabetes, sleep apnea, kidney disease, cancer and arthritis are igniting demand for innovative medical solutions. The nation’s well-established healthcare infrastructure, coupled with rapid adoption of advanced medical technologies and the presence of top industry companies, provides a solid foundation for continuing growth in medical device manufacturers.

What is the future of medical device manufacturing?

The U.S. dominated the medical device manufacturing industry with 41% market share in 2024.1 By 2033 that share will reach $51.76 billion – a CAGR of 13.77% from 2025.2 The global market is projected to increase 12.58% to almost $422 billion by 2033.3

Several specialized medical devices are driving growth in the U.S. market. In response to the rising prevalence of chronic illnesses and age-related diseases, medical device manufacturers are prioritizing development of innovative technologies tailored to address these specific health challenges.

Medical device manufacturing companies are also investing heavily in research and development to create advanced tools that improve patient outcomes, enhance early diagnosis and support effective disease management. This equipment includes:

• Cardiology devices such as pacemakers to address heart-related conditions.
  
  
• Diagnostic imaging machines — including MRI, CT and ultrasound systems — which support a broad range of analytic needs.
  
  
• Orthopedic devices, like joint implants, which are in high demand due to the aging population and the prevalence of arthritis and other musculoskeletal issues.

Ophthalmic devices for eye conditions and general and plastic surgery tools are also expanding in market presence. The rise of remote monitoring devices and portable diagnostic tools, especially those used for at-home care, is accelerating as the industry shifts toward decentralized healthcare delivery.

Medical device manufacturers face regulatory, supply chain and competitive pressures.

Despite strong growth and innovation in the U.S. medical device manufacturing sector, barriers continue to challenge companies in the industry. Regulatory compliance remains a significant hurdle, as manufacturers must navigate complex FDA and other approval processes, which can be both time-consuming and costly.

Supply chain disruptions and shortages of critical components can impact production timelines and increase costs. Intellectual property protection and cybersecurity risks are also growing concerns, especially with the rise of digital and connected medical devices.

Medical device manufacturers also face intense competition, both domestically and globally, which requires ongoing investment in research, development and talent to stay ahead. Rising costs for materials and labor, along with the need to adapt to rapidly changing technologies add further pressure.

These barriers, while challenging, also present opportunities for companies to innovate and differentiate themselves in the marketplace.

Take advantage of regulatory opportunities.

Medical device manufacturers must follow extensive government regulations which, while critical to maintaining safety and efficacy, can be costly and inhibit speed to market for life-saving tools. Although standard device approval processes slowed during the pandemic, pre-market approvals and 510(k) clearances have since returned to normal or slightly increased.

Keeping abreast of regulatory trends and identifying pathways that expedite market entry is imperative for medical device manufacturing companies. For example, with increased approvals, companies can now focus efforts on optimizing product development cycles to align with these processes.

Additionally, governmental flexibility in facilitating remote care and rapid product approvals provides a foundation for medical device manufacturers to advocate for regulatory reforms that permanently support at-home healthcare delivery models. When manufacturers engage in policy discussions and lobby for such changes, they can help shape a regulatory environment that enables faster and more efficient product launches, benefiting providers and patients with quicker access to essential medical technologies.

Eliminate weaknesses in the supply chain.

During the pandemic, global communities were simultaneously trying to access the same equipment. This spike in demand exposed critical weaknesses in the medical device supply chain which continue to plague the industry.

Supply chain disruptions can have particularly negative effects on heavily regulated industries like healthcare. A medical device manufacturer can't simply go out and source a different supplier to deliver a component it needs for production without first clearing certain regulatory hurdles.

Lawmakers and governmental agencies are still focusing on ways to shore up the medical device supply chain to mitigate ongoing industry conditions in the future. However, medical device manufacturers and technology companies should also develop their own strategies to ensure they maintain a resilient supply chain in the event of external disruptions. Such strategies should include adopting logistics and infrastructure partnerships, supply chain management software and other smart technology. Of course, maintaining cash flow to stock up ahead of anticipated shortages is essential, as well.

Support telehealth technology.

Medical professionals need the right tools to facilitate patient interaction and maintain appropriate levels of care and patient outcomes. Patients and providers are now comfortable with virtual care. Eighty percent of physicians in hospital practices and 68.4% of doctors in private practices use telehealth technologies, including remote patient monitoring, videoconferencing and audio-only methods.4

Remote monitoring is a leading tool for telehealth services, with the devices’ projected CAGR to grow 12.58% by 2030.5 Physicians and hospital staff alike are keen on telehealth technologies because they help alleviate stress from a strained healthcare system. Six medical specialties use them for more than 20% of their weekly visits.5

• Psychiatry (68.2%)
• Neurology (32.2%)
• Endocrinology (24.2%)
• Gastroenterology (20.4%)
• Family and General Medicine (20.1%)
• Urology (18.7%)

Telehealth expands patient access to quality healthcare while reducing the burden on traditional medical systems. Providers who embrace telehealth solutions can enhance patient outcomes, increase efficiency and ensure safe, convenient care from anywhere.

Adopt new business models.

Telehealth technologies offer enormous potential for both medical device manufacturing companies and the healthcare industry in general, but they also require heavy financial investment. This all translates to higher cost of ownership for patients, particularly as insurance companies and Medicare adopt lower reimbursement policies. Record-breaking inflation further compounds the financial implications.

As reimbursements, hospital budgets and consumer buying power shrinks, so do device manufacturers’ profit margins. Medical device manufacturing companies also face increased competition as new players from other industries enter the medical device marketplace. Under these market conditions, traditional medical device companies risk being reduced to commodity status in the middle of the healthcare value chain.

To ensure competitive advantage, medical technology companies will have to re-think their business models and reposition themselves to demonstrate real value, beyond traditional research and development and innovation — to one that outlines a clear, sustainable contribution to overall healthcare. Identifying ways to use technology to not only advance care and access, but to help address rising healthcare costs is critical. The goal is to demonstrate improved quality of care while lowering costs.

Data and analytics offer potential to improve care, reduce costs and remain competitive. Medical devices capture valuable, real-world data for better decisioning. As technology continues to evolve, medical device companies can integrate services and data intelligence to strengthen their position within the healthcare value chain. Those who do will benefit from new revenue streams and gain closer access to customers, patients and consumers.

Partner with investors to capitalize on AI innovation and fuel growth.

With emerging markets, technologies and opportunities in continuous development, medical device manufacturers need financial agility to keep pace. Funding is necessary to finance new ventures and for competitive positioning.

Venture capitalists are up to the challenge. Healthcare technology startup funding is active and growing. In third quarter, startups raised almost $4 billion — up 12% from the previous quarter — with a record average deal size of almost $7.7 million.6

Artificial intelligence, which was among the largest 2025 third quarter funding rounds, is driving the high investment activity – most notably tools that help to manage workflows and administrative work. For example, Ambience Healthcare raised $243 million in Series C funding for clinical documentation and AI medical information platform OpenEvidence raised $210 million in Series B funding.7 Abridge also secured investments totaling $757.5 million for ambient notetaking scribes that record and transcribe patient-doctor conversations into clinical notes.8

Venture capitalists can help facilitate the financial agility needed for rapid innovation and competitive growth. In turn, medical device manufacturers gain access to essential funding and strategic expertise that accelerate product development and market expansion.

Ensure access to necessary working capital.

Medical device manufacturing offers abundant opportunities for those with the imagination, flexibility and capital to meet emerging healthcare needs. Synovus provides loans, credit products and treasury management services for a comprehensive financial solution. For more information on securing capital for your medical device manufacturing enterprise, contact a Synovus Commercial Banker or stop by one of our local branches.